share_log

Aditxt | 424B3: Prospectus

Aditxt | 424B3: Prospectus

Aditxt | 424B3：募资说明书
美股SEC公告 ·  2024/10/07 20:58

Moomoo AI 已提取核心信息

Aditxt, Inc. has updated its prospectus supplement related to the resale of up to 3,750,000 shares of common stock to Seven Knots, LLC under a previously established purchase agreement. The supplement, filed on October 7, 2024, follows a reverse stock split that became effective on October 1, 2024, and includes updated information post-split. The agreement with Seven Knots, which was entered into on May 2, 2024, allows Aditxt to direct Seven Knots to purchase shares of its common stock up to a total maximum aggregate purchase price of $150 million. The shares may be sold to Seven Knots at Aditxt's discretion, subject to certain conditions, and Seven Knots may then resell these shares to the public. The prospectus supplement also outlines the terms of a Registration...Show More
Aditxt, Inc. has updated its prospectus supplement related to the resale of up to 3,750,000 shares of common stock to Seven Knots, LLC under a previously established purchase agreement. The supplement, filed on October 7, 2024, follows a reverse stock split that became effective on October 1, 2024, and includes updated information post-split. The agreement with Seven Knots, which was entered into on May 2, 2024, allows Aditxt to direct Seven Knots to purchase shares of its common stock up to a total maximum aggregate purchase price of $150 million. The shares may be sold to Seven Knots at Aditxt's discretion, subject to certain conditions, and Seven Knots may then resell these shares to the public. The prospectus supplement also outlines the terms of a Registration Rights Agreement, which requires Aditxt to file a registration statement for the resale of the shares issued to Seven Knots. Aditxt has obtained stockholder approval for the issuance of shares above the Nasdaq Exchange Cap and has the right to terminate the purchase agreement at any time. The sale of a significant number of shares by Seven Knots could potentially affect the market price of Aditxt's common stock.
Aditxt, Inc.已更新其招股说明书补充，涉及最多375万股普通股向Seven Knots, LLC在之前确定的购买协议下的转售。这份补充材料于2024年10月7日提交，紧随2024年10月1日生效的股票逆向拆分，并包含拆分后的更新信息。与Seven Knots签订的协议于2024年5月2日达成，允许Aditxt指示Seven Knots购买其普通股，最高总购买价格为15000万美元。这些股份可能由Aditxt自行出售给Seven Knots，但需符合一定条件，Seven Knots随后可以将这些股份转售给公众。招股说明书还概述了一项登记权协议的条款，要求Aditxt为向Seven Knots发行的股份进行登记声明。Aditxt已获得股东批准以超过纳斯达克交易所规定的股份上限进行发行，并有权随时终止购买协议。Seven Knots出售大量股份可能会对Aditxt的普通股市场价格产生影响。
Aditxt, Inc.已更新其招股说明书补充，涉及最多375万股普通股向Seven Knots, LLC在之前确定的购买协议下的转售。这份补充材料于2024年10月7日提交，紧随2024年10月1日生效的股票逆向拆分，并包含拆分后的更新信息。与Seven Knots签订的协议于2024年5月2日达成，允许Aditxt指示Seven Knots购买其普通股，最高总购买价格为15000万美元。这些股份可能由Aditxt自行出售给Seven Knots，但需符合一定条件，Seven Knots随后可以将这些股份转售给公众。招股说明书还概述了一项登记权协议的条款，要求Aditxt为向Seven Knots发行的股份进行登记声明。Aditxt已获得股东批准以超过纳斯达克交易所规定的股份上限进行发行，并有权随时终止购买协议。Seven Knots出售大量股份可能会对Aditxt的普通股市场价格产生影响。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Lexeo Therapeutics
    LXEO
    -- 4.090
    Polyrizon
    PLRZ
    -- 0.750
    Dominari Holdings
    DOMH
    -- 5.490
    Tonix Pharmaceuticals
    TNXP
    -- 30.5100
    Codexis
    CDXS
    -- 3.070
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    FOMC维持利率但不确定性高企：美股后市走向如何？
    🎙️讨论 1. 美联储强调政策路径存在“高度不确定性”，你更关注利率预期变化还是经济数据对市场的短期影响？ 2. 若核心通胀维持高位，哪类板块更具交易机会——防御型股票还是科技成长股？ 展开
    联邦公开市场委员会新闻发布会，2025年3月19日